Skip to search formSkip to main contentSkip to account menu

ICI-176334

Known as: ICI 176,334, ICI 176334 
National Institutes of Health

Related topics

Related topics

2 relations
Casodex

Broader (1)

bicalutamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
French multicentre trial comparing Casodex (ICI 176,334) monotherapy with castration plus nilutamide in metastatic prostate cancer: a preliminary report.
This trial compares Casodex (ICI 176,334) monotherapy with the combination of castration (medical or surgical) plus nilutamide… 
1990
1990
The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
The effect of the steroidal androgen receptor antagonist Win 49,596 on the prostate and testis was studied in beagle dogs and was… 
Review
1989
Review
1989
"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
The relative merits of the steroidal anti-androgen, cyproterone acetate, and the non-steroidal anti-androgens flutamide and… 
1989
1989
Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
1989
1989
Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results.
Following promising results in animal studies, Casodex (ICI 176,334) has been studied in the treatment of patients with advanced… 
1988
1988
ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
1987
1987
ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
Pure antiandrogens, like flutamide, antagonize androgen action both peripherally and centrally at the hypothalamic-pituitary axis… 
1987
1987
Studies on a novel antiandrogen: ICI 176334
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)